• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

  • Private Companies
  • Publicly Listed
  • Exited Investments

  • Acutus
    Medical

    Cardiac mapping system for AF

  • Agenus
    (4-Antibody)

    Broad immunotherapy platform for cancer

  • Aleta
    Biotherapeutics

    Transformative adoptive cell therapy

  • Algeta

    Alpha-emitter anticancer agents

  • Alpha
    Anomeric

    Novel oligonucleotide chemistry platform

  • Amphista
    Therapeutics

    Targeted Protein Degradation

  • Aravive

    Therapies targeting survival pathways for cancer

  • Argá
    Medtech

    Next Generation Cardiac Ablation

  • Arrakis
    Therapeutics

    Small molecule modulators of RNA

  • Artax
    Biopharma

    Novel therapy for autoimmune disease

  • Aura
    Biosciences

    Novel therapies for ocular cancers

  • Aviadobio

    Revolution in gene therapy for neurodegenerative disorders

  • Avila

    Covalent small molecule platform

  • Axonics
    Modulation
    Technologies

    Novel sacral neuromodulation system

  • Biocartis

    Molecular diagnostics platform

  • CardiacAssist

    Extracorporeal ventricular assist device

  • CardiAQ
    Valve
    Technologies

    Novel device for mitral valve replacement

  • CardioKine

    Cardio-renal drug development

  • Cellnovo

    Micro insulin pump with connectivity

  • Centessa
    Pharmaceuticals
    (Capella)

    Novel asset-centric pharmaceutical company

  • CN
    Creative

    Nicotine replacement e-cigarette

  • Conatus
    Pharmaceuticals

    Therapeutics for liver disease

  • Curve
    Therapeutics

    Next-gen functional discovery platform

  • Eloxx
    Pharmaceuticals
    (Zikani)

    Ribosome Modulating Agents for Rare Disease

  • Emergent
    Biosolutions

    Innovative vaccines and therapeutics

  • Epitopea

    Next generation immunotherapies

  • EUSA
    Pharma

    Trans-Atlantic specialty pharma company

  • F2G

    Novel anti-fungal therapy

  • Highlight
    Therapeutics

    Bridging the innate to adaptive immune response

  • Infinity
    Pharmaceuticals

    Chemical genomic-based drug discovery

  • Iterum
    Therapeutics

    Novel oral antibiotic

  • KaNDy
    Therapeutics

    Therapeutics for Women’s Health

  • KuDos
    Pharmaceuticals

    DNA damage repair therapy

  • Levicept

    Novel pain treatment for osteoarthritis

  • Micromet

    Bi-specific antibodies

  • MiroBio

    Immune cell regulation

  • Moximed

    Novel device for treating osteoarthritis of the knee

  • Nalu
    Medical

    Novel spinal cord stimulation device

  • NeRRe
    Therapeutics

    Pipeline of neurokinin antagonists

  • Orphalan

    Rare disease company

  • Pheno
    Therapeutics

    Remyelinating therapy development

  • Pic
    Therapeutics

    Targeting oncogene translation

  • PowderMed

    Needle-free vaccine delivery

  • Proximie

    Best-in-class technology for connected surgical care

  • Rappta
    Therapeutics

    Novel PP2A activators to treat cancer

  • RespiVert

    Novel therapies for respiratory disorders

  • Santarus

    Speciality pharmaceuticals

  • Speciality
    European
    Pharma

    European pharma focused on urology

  • Thiakis

    Novel hormone treatment for obesity

  • Tridek-One

    Novel approach for treatment of vasculitis

  • UniQure

    Gene therapy for rare disease

  • Ventus
    Medical

    Innovative smoking cessation products



  • Privacy Policy
  • Legal and Regulatory Matters

©2022 Advent Life Sciences